MedTrace Logo

Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke

NCT06470477 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2024-06-24

No results posted yet for this study

Summary

The molecular characteristics of ischemic stroke with phlegm-heat syndrome and candidate biomarkers were identified based on multi-omics data. The main purpose of this study is to validate the molecular characteristics and biomarkers of phlegm-heat syndrome in ischemic stroke, and to demonstrate the association of biomarkers with clinical outcomes.

Conditions

  • Ischemic Stroke, Acute

Interventions

DRUG

Guideline-based treatment

Guideline-based treatment includes anti-platelet therapy, control of vascular risk factors, and so on.

Sponsors & Collaborators

  • Dongzhimen Hospital, Beijing

    lead OTHER

Principal Investigators

  • Ying Gao, M.D. · Dongzhimen Hospital, Beijing

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470477 on ClinicalTrials.gov